Thus, new BCC models such as Ptchf/f CD4Cre mice will not only allow to investigate BCC-initiating events beyond Hh/Ptch-signaling activation but, also, to develop new BCC treatment options. The gene discussed is PTCH1; the disease is skin basal cell carcinoma.